Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02601378
Title A Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

uveal melanoma

Therapies

HDM201 + IDE196

IDE196

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.